<?xml version="1.0" encoding="utf-8"?> <rss version="2.0"><channel><title>RSS Feed on Applied Radiology</title><link>http://www.appliedradiology.com</link><description> RSS Feed on Applied Radiology</description><item><title>Implications of the recent CMS PET coverage decision</title><link>http://www.appliedradiology.com//Issues/2009/05/Editorials/Implications-of-the-recent-CMS-PET-coverage-decision.aspx</link><description>&lt;p&gt; 
   
   Dr. Czernin 

  is Chief of Nuclear Medicine, Department of Molecular and Medical
  Pharmacology, David Geffen School of Medicine, University of
  California, Los Angeles. 
 

 Positron emission tomography/computed tomography (PET-CT)
scanners using the radioisotope 18F-fluorodeoxyglucose (FDG) have&lt;/p&gt;</description><author></author><pubDate>Tuesday, 19 May 2009 11:06:08 GMT</pubDate></item></channel></rss>